Haemonetics (HAE) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Haemonetics · Health Care · ref. ETF XLV · 79 calls · price $105
What the company does: Haemonetics Corporation, a medical technology company, provides a suite of hospital technologies solutions.
📈 Haemonetics (HAE) stock price
$105+93.2% over range
Aug 28, 25low $47.67 · high $108.8Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
71% recommend buying · 7 analysts
📊 JPI status : Haemonetics is no longer in our current JPI rankings, but appeared in the past (2022) — its upside may be behind it. See the stocks picked in 2022 →
⚠️ The stock trades above the median target: it has beaten expectations. The “Buy” reflects conviction on the company, but the remaining quantified upside is low/negative.
🎯 HAE price target & analyst consensus — price $105
The price target · all analysts combined (7 targets)
Highest target · 1 firm of 7$119+13.3%
Median target · of 7 targets$92-12.4%
Lowest target · 1 firm of 7$80-23.8%
Current price$105
Where these 7 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
343%
$110 ↔ $119
Below
457%
$80 ↔ $92
⏳ Targets haven't kept up with the price. 71% of ratings say “Buy”, yet 4 of 7 targets sit below the current price: the stock has risen past what analysts were aiming for, and some haven't raised their target yet. Read it as a dated view, not as a forecast of a drop.
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: Mizuho — 64% of its targets hit on this sector (70 calls tested). It aims for $90 (-14 %), call made on July 16, 2026, maturing on July 16, 2027 (43 d ago).
The 4 reliable analysts
$101-3.8 %
The 3 other firms
$86-18 %
How to read it: the 4 reliable firms are not filtered by optimism — 2 aim above the price, 2 below, hence their $101 median. “The 3 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 7 ratings (last 6 months)
Strong Buy00%
Buy571%
Hold229%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 HAE price target all
All 79 calls, one by one, with our verdict on each firm.
→ See all 79 targets, analyst by analyst💡 The best analysts on HAE most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in HAE? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Haemonetics? The JPI assistant answers using our backtest data.
📈 Haemonetics fundamentals: valuation, margins & growth › open the full page
P/E 51.5Net margin 7.1 %Revenue growth +5.6 %High P/E
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2023
marg. 10 %
2024
Rev +12%Profit +2%
2025
Rev +4%Profit +43%
2026
Rev −2%Profit −42%
🔎 Detailed analyses
🏛️ Which US Congress members hold Haemonetics (HAE)?
3 Congress members have disclosed HAE buys. Click a highlighted name to see their track record (do they beat the S&P 500?).
✅ Historical analyst reliability on HAE
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| Mizuho ↗ | 60% | +12.4% | 5 |
| Jefferies ↗ | 60% | +4.2% | 10 |
| Morgan Stanley ↗ | 56% | -6.0% | 9 |
| JMP Securities | 55% | +10.8% | 11 |
| Barrington Research ↗ | 42% | -1.0% | 24 |
| Raymond James ↗ | 42% | -6.0% | 24 |
| Needham ↗ | 27% | -10.9% | 11 |
| Citigroup ↗ | 0% | -3.0% | 2 |
📊 What $1,000 invested in Haemonetics would be worth › open the full page
In short — $1,000 invested in Haemonetics 10 years ago would be worth $2,326 today, i.e. +9%/yr on average. Best year: 2018 (+72%), worst: 2021 (-55%). Price performance, excluding dividends.
If I'd invested $1,000 in Haemonetics
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $961 | -4% |
| 3 years ago | $954 | -5% |
| 5 years ago | $632 | -37% |
Return by year (Haemonetics)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | -6% | $936 (-6%) |
| 2025 | +3% | $961 (-4%) |
| 2024 | -9% | $877 (-12%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Haemonetics
Loading news…
📋 All analyst calls on HAE
Filtered on — · ✕ show all
▲ Outperform · 🎯$119
Price at call : $108.8 — upside +9%
Today : $105 — upside +13%
🎯 on HAE : 100% (1 call matured) · 📊 on Health : 48.7% · +1.8% (76 calls)
in progress (365j)
matures : Aug 21, 27
matures : Aug 21, 27
Barrington Research ↗
Aug 19, 26
▲ Outperform · 🎯$118
Price at call : $108.22 — upside +9%
Today : $105 — upside +12%
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
in progress (365j)
matures : Aug 19, 27
matures : Aug 19, 27
▲ Buy · 🎯$110
Price at call : $108.41 — upside +1%
Today : $105 — upside +5%
🎯 on HAE : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Aug 18, 27
matures : Aug 18, 27
■ Neutral neutral · not a buy · 🎯$92
Price at call : $86.61 — gap to target +6%
Today : $105 — gap to target -12%
🎯 on HAE : 0% (1 call matured) · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
■ Neutral neutral · not a buy · 🎯$86
Price at call : $86.61 — gap to target -1%
Today : $105 — gap to target -18%
🎯 on HAE : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Aug 7, 27
matures : Aug 7, 27
▲ Buy · 🎯$96
Price at call : $87.84 — upside +9%
Today : $105 — upside -9%
🎯 on HAE : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Aug 6, 27
matures : Aug 6, 27
▲ Outperform · 🎯$90
Price at call : $78.5 — upside +15%
Today : $105 — upside -14%
🎯 on HAE : 100% (1 call matured) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Jul 15, 27
matures : Jul 15, 27
▲ Buy · 🎯$84
Price at call : $77.29 — upside +9%
Today : $105 — upside -20%
🎯 on HAE : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Jun 26, 27
matures : Jun 26, 27
See the other 71 calls, newest to oldest
▲ Buy · 🎯$84
Price at call : $72.73 — upside +15%
Today : $105 — upside -20%
🎯 on HAE : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Jun 17, 27
matures : Jun 17, 27
▲ Outperform · 🎯$85
Price at call : $74.43 — upside +14%
Today : $105 — upside -19%
🎯 on HAE : 100% (1 call matured) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Jun 15, 27
matures : Jun 15, 27
■ Neutral neutral · not a buy · 🎯$70
Price at call : $67.81 — gap to target +3%
Today : $105 — gap to target -33%
🎯 on HAE : 0% (1 call matured) · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : May 28, 27
matures : May 28, 27
B of A Securities ↗
May 22, 26
▲ Buy · 🎯$80
Price at call : $65.49 — upside +22%
Today : $105 — upside -24%
🎯 on HAE : no call matured yet · 📊 on Health : 64.8% · +20.2% (105 calls)
in progress (365j)
matures : May 22, 27
matures : May 22, 27
Barrington Research ↗
May 12, 26
▲ Outperform · 🎯$89
Price at call : $57.01 — upside +56%
Today : $105 — upside -15%
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
in progress (365j)
matures : May 12, 27
matures : May 12, 27
■ Neutral neutral · not a buy · 🎯$62
Price at call : $52.24 — gap to target +19%
Today : $105 — gap to target -41%
🎯 on HAE : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : May 8, 27
matures : May 8, 27
▲ Outperform · 🎯$70
Price at call : $60.48 — upside +16%
Today : $105 — upside -33%
🎯 on HAE : 100% (1 call matured) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
■ Neutral neutral · not a buy · 🎯$64
Price at call : $59.53 — gap to target +8%
Today : $105 — gap to target -39%
🎯 on HAE : 0% (1 call matured) · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Apr 7, 27
matures : Apr 7, 27
■ Neutral neutral · not a buy · 🎯$70
Price at call : $59.49 — gap to target +18%
Today : $105 — gap to target -33%
🎯 on HAE : 0% (1 call matured) · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Mar 11, 27
matures : Mar 11, 27
■ Neutral neutral · not a buy · 🎯$75
Price at call : $57.69 — gap to target +30%
Today : $105 — gap to target -29%
🎯 on HAE : 0% (1 call matured) · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
▲ Outperform · 🎯$80
Price at call : $59.34 — upside +35%
Today : $105 — upside -24%
🎯 on HAE : 100% (1 call matured) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
Barrington Research ↗
Feb 6, 26
▲ Outperform · 🎯$94
Price at call : $59.34 — upside +58%
Today : $105 — upside -10%
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
▲ Buy · 🎯$88
Price at call : $59.34 — upside +48%
Today : $105 — upside -16%
🎯 on HAE : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Feb 6, 27
matures : Feb 6, 27
Barrington Research ↗
Feb 2, 26
▲ Outperform · 🎯$93
Price at call : $65.78 — upside +41%
Today : $105 — upside -11%
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
in progress (365j)
matures : Feb 2, 27
matures : Feb 2, 27
Barrington Research ↗
Jan 12, 26
▲ Outperform · 🎯$93
Price at call : $82.92 — upside +12%
Today : $105 — upside -11%
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
in progress (365j)
matures : Jan 12, 27
matures : Jan 12, 27
▲ Buy · 🎯$88
Price at call : $82.03 — upside +7%
Today : $105 — upside -16%
🎯 on HAE : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
▲ Outperform · 🎯$90
Price at call : $79.98 — upside +13%
Today : $105 — upside -14%
🎯 on HAE : 100% (1 call matured) · 📊 on Health : 57.1% · +12.3% (70 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
▲ Outperform · 🎯$99
Price at call : $81.11 — upside +22%
Today : $105 — upside -6%
🎯 on HAE : 100% (1 call matured) · 📊 on Health : 48.7% · +1.8% (76 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
■ Hold neutral · not a buy
🎯 on HAE : 33% (3 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
in progress (365j)
matures : Dec 15, 26
matures : Dec 15, 26
■ Neutral neutral · not a buy · 🎯$74
Price at call : $80.4 — gap to target -8%
Today : $105 — gap to target -30%
🎯 on HAE : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Dec 12, 26
matures : Dec 12, 26
■ Neutral neutral · not a buy · 🎯$88
Price at call : $84.45 — gap to target +4%
Today : $105 — gap to target -16%
🎯 on HAE : 0% (1 call matured) · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Dec 11, 26
matures : Dec 11, 26
▲ Buy · 🎯$88
Price at call : $78.79 — upside +12%
Today : $105 — upside -16%
🎯 on HAE : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Nov 21, 26
matures : Nov 21, 26
Barrington Research ↗
Nov 7, 25
▲ Outperform · 🎯$90
Price at call : $68.36 — upside +32%
Today : $105 — upside -14%
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
▲ Buy · 🎯$78
Price at call : $68.36 — upside +14%
Today : $105 — upside -26%
🎯 on HAE : 33% (3 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
in progress (365j)
matures : Nov 7, 26
matures : Nov 7, 26
▲ Buy · 🎯$88
Price at call : $68.36 — upside +29%
Today : $105 — upside -16%
🎯 on HAE : no call matured yet · 📊 on Health : 51.2% · +9.4% (41 calls)
in progress (365j)
matures : Nov 6, 26
matures : Nov 6, 26
Barrington Research ↗
Oct 21, 25
▲ Outperform · 🎯$86
Price at call : $51.34 — upside +68%
Today : $105 — upside -18%
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
in progress (365j)
matures : Oct 21, 26
matures : Oct 21, 26
▲ Buy · 🎯$64
Price at call : $50.98 — upside +26%
Today : $105 — upside -39%
🎯 on HAE : 0% (1 call matured) · 📊 on Health : 56% · +15.7% (125 calls)
in progress (365j)
matures : Oct 7, 26
matures : Oct 7, 26
Barrington Research ↗
Sep 23, 25
▲ Outperform · 🎯$86
Price at call : $50.61 — upside +70%
Today : $105 — upside -18%
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
in progress (365j)
matures : Sep 23, 26
matures : Sep 23, 26
Raymond James ↗
Aug 11, 25
▲ Outperform · 🎯$78
Price at call : $52.47 — upside +49%
Today : $105 — upside -26%
Expected +49% · Actual +66% · Reason (≥ +15%) : ✓ Yes
🎯 on HAE : 58% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
+66.2%
stock +66% · XLV +29%
matured Aug 11, 26
Barrington Research ↗
Aug 8, 25
▲ Outperform · 🎯$86
Price at call : $53.99 — upside +59%
Today : $105 — upside -18%
Expected +59% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
+60.4%
stock +60% · XLV +29%
matured Aug 8, 26
▲ Outperform · 🎯$70
Price at call : $53.99 — upside +30%
Today : $105 — upside -33%
Expected +30% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on HAE : 100% (1 call matured) · 📊 on Health : 57.1% · +12.3% (70 calls)
+60.4%
stock +60% · XLV +29%
matured Aug 8, 26
■ Neutral neutral · not a buy · 🎯$62
Price at call : $53.99 — gap to target +15%
Today : $105 — gap to target -41%
🎯 on HAE : no call matured yet · 📊 on Health : 49.3% · +6.2% (142 calls)
in progress (365j)
matures : Aug 8, 26
matures : Aug 8, 26
▲ Buy · 🎯$68
Price at call : $53.99 — upside +26%
Today : $105 — upside -35%
Expected +26% · Actual +60% · Reason (≥ +15%) : ✓ Yes
🎯 on HAE : 33% (3 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
+60.4%
stock +60% · XLV +29%
matured Aug 7, 26
Barrington Research ↗
Jul 11, 25
▲ Outperform · 🎯$95
Price at call : $75.52 — upside +26%
Today : $105 — upside -10%
Expected +26% · Actual +2% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
+1.8%
stock +2% · XLV +19%
matured Jul 11, 26
▲ Buy · 🎯$90
Price at call : $77.52 — upside +16%
Today : $105 — upside -14%
Expected +16% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 0% (1 call matured) · 📊 on Health : 56% · +15.7% (125 calls)
-3.3%
stock -3% · XLV +20%
matured Jul 9, 26
▲ Outperform · 🎯$87
Price at call : $74.77 — upside +16%
Today : $105 — upside -17%
Expected +16% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 100% (1 call matured) · 📊 on Health : 48.7% · +1.8% (76 calls)
+3.4%
stock +3% · XLV +19%
matured Jun 26, 26
JMP Securities
May 20, 25
▲ Market Outperform · 🎯$100
Price at call : $68.91 — upside +45%
Today : $105 — upside -5%
Expected +45% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 0% (2 calls matureds) · 📊 unranked overall
-13.6%
stock -14% · XLV +9%
matured May 20, 26
Raymond James ↗
May 9, 25
▲ Strong Buy · 🎯$105
Price at call : $70.23 — upside +50%
Today : $105 — upside +0%
Expected +50% · Actual -26% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 58% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
-25.6%
stock -26% · XLV +5%
matured May 9, 26
▲ Buy · 🎯$84
Price at call : $68.19 — upside +23%
Today : $105 — upside -20%
Expected +23% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 33% (3 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
-23.4%
stock -23% · XLV +8%
matured May 8, 26
Raymond James ↗
Feb 7, 25
▲ Strong Buy · 🎯$115
Price at call : $60.64 — upside +90%
Today : $105 — upside +10%
Expected +90% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 58% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
-4.9%
stock -5% · XLV +7%
matured Feb 7, 26
JMP Securities
Feb 7, 25
▲ Market Outperform · 🎯$100
Price at call : $60.64 — upside +65%
Today : $105 — upside -5%
Expected +65% · Actual -5% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 0% (2 calls matureds) · 📊 unranked overall
-4.9%
stock -5% · XLV +7%
matured Feb 7, 26
▲ Buy · 🎯$108
Price at call : $59.34 — upside +82%
Today : $105 — upside +3%
Expected +82% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 33% (3 calls matureds) · 📊 on Health : 46% · +1.9% (137 calls)
-2.8%
stock -3% · XLV +7%
matured Feb 7, 26
Barrington Research ↗
Feb 7, 25
▲ Outperform · 🎯$95
Price at call : $59.34 — upside +60%
Today : $105 — upside -10%
Expected +60% · Actual -3% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
-2.8%
stock -3% · XLV +7%
matured Feb 7, 26
Barrington Research ↗
Dec 4, 24
▲ Outperform · 🎯$108
Price at call : $83.51 — upside +29%
Today : $105 — upside +3%
Expected +29% · Actual +0% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
+0.4%
stock +0% · XLV +5%
matured Dec 4, 25
Barrington Research ↗
Nov 8, 24
▲ Outperform · 🎯$108
Price at call : $91.4 — upside +18%
Today : $105 — upside +3%
Expected +18% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
-22.9%
stock -23% · XLV -1%
matured Nov 8, 25
Raymond James ↗
Nov 8, 24
▲ Strong Buy · 🎯$120
Price at call : $87.42 — upside +37%
Today : $105 — upside +14%
Expected +37% · Actual -19% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 58% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
-19.4%
stock -19% · XLV -2%
matured Nov 8, 25
Barrington Research ↗
Sep 23, 24
▲ Outperform · 🎯$108
Price at call : $75.49 — upside +43%
Today : $105 — upside +3%
Expected +43% · Actual -33% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
-33.0%
stock -33% · XLV -11%
matured Sep 23, 25
Barrington Research ↗
Aug 9, 24
▲ Outperform · 🎯$108
Price at call : $74.66 — upside +45%
Today : $105 — upside +3%
Expected +45% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
-29.7%
stock -30% · XLV -13%
matured Aug 9, 25
Barrington Research ↗
May 10, 24
▲ Outperform · 🎯$107
Price at call : $96.21 — upside +11%
Today : $105 — upside +2%
Expected +11% · Actual -27% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
-27.0%
stock -27% · XLV -5%
matured May 10, 25
Barrington Research ↗
Apr 12, 24
▲ Outperform · 🎯$105
Price at call : $84.88 — upside +24%
Today : $105 — upside +0%
Expected +24% · Actual -30% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
-30.0%
stock -30% · XLV -0%
matured Apr 12, 25
Barrington Research ↗
Feb 13, 24
▲ Outperform · 🎯$105
Price at call : $71.24 — upside +47%
Today : $105 — upside +0%
Expected +47% · Actual -13% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
-12.6%
stock -13% · XLV +2%
matured Feb 12, 25
Barrington Research ↗
Nov 3, 23
▲ Outperform · 🎯$105
Price at call : $88.46 — upside +19%
Today : $105 — upside +0%
Expected +19% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
-16.9%
stock -17% · XLV +14%
matured Nov 2, 24
Barrington Research ↗
Aug 9, 23
▲ Outperform · 🎯$114
Price at call : $90.97 — upside +25%
Today : $105 — upside +9%
Expected +25% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 25% (12 calls matureds) · 📊 on Health : 29.7% · -10.2% (74 calls)
-15.3%
stock -15% · XLV +11%
matured Aug 8, 24
Raymond James ↗
Nov 8, 22
▲ Outperform · 🎯$100
Price at call : $83.98 — upside +19%
Today : $105 — upside -5%
Expected +19% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 58% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
+2.6%
stock +3% · XLV -4%
matured Nov 8, 23
Raymond James ↗
Aug 11, 22
▲ Outperform · 🎯$88
Price at call : $73.07 — upside +20%
Today : $105 — upside -16%
Expected +20% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on HAE : 58% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
+24.9%
stock +25% · XLV +3%
matured Aug 11, 23
Raymond James ↗
Jul 1, 22
▲ Outperform · 🎯$76
Price at call : $67.32 — upside +13%
Today : $105 — upside -28%
Expected +13% · Actual +25% · Reason (≥ +15%) : ✓ Yes
🎯 on HAE : 58% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
+24.6%
stock +25% · XLV +2%
matured Jul 1, 23
Raymond James ↗
May 11, 22
▲ Outperform · 🎯$63
Price at call : $51.19 — upside +23%
Today : $105 — upside -40%
Expected +23% · Actual +68% · Reason (≥ +15%) : ✓ Yes
🎯 on HAE : 58% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
+67.7%
stock +68% · XLV +5%
matured May 11, 23
Raymond James ↗
Feb 9, 22
▲ Outperform · 🎯$66
Price at call : $56.92 — upside +16%
Today : $105 — upside -37%
Expected +16% · Actual +41% · Reason (≥ +15%) : ✓ Yes
🎯 on HAE : 58% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
+41.3%
stock +41% · XLV -2%
matured Feb 9, 23
Raymond James ↗
Nov 10, 21
▲ Outperform · 🎯$70
Price at call : $61.51 — upside +14%
Today : $105 — upside -33%
Expected +14% · Actual +35% · Reason (≥ +15%) : ✓ Yes
🎯 on HAE : 58% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
+35.0%
stock +35% · XLV +1%
matured Nov 10, 22
▲ Buy · 🎯$85
Price at call : $56 — upside +52%
Today : $105 — upside -19%
Expected +52% · Actual +3% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 60% (10 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+2.9%
stock +3% · XLV +5%
matured May 14, 22
Raymond James ↗
Feb 12, 21
▲ Outperform · 🎯$155
Price at call : $134.78 — upside +15%
Today : $105 — upside +48%
Expected +15% · Actual -57% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 58% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
-56.9%
stock -57% · XLV +10%
matured Feb 12, 22
Raymond James ↗
Feb 3, 21
▲ Outperform · 🎯$145
Price at call : $129.77 — upside +12%
Today : $105 — upside +38%
Expected +12% · Actual -65% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 58% (12 calls matureds) · 📊 on Health : 42.1% · -4.4% (114 calls)
-64.5%
stock -65% · XLV +15%
matured Feb 3, 22
▲ Buy · 🎯$110
Price at call : $95.75 — upside +15%
Today : $105 — upside +5%
Expected +15% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on HAE : 60% (10 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+17.1%
stock +17% · XLV +7%
matured Jun 14, 19
▲ Buy · 🎯$40
Price at call : $34.5 — upside +16%
Today : $105 — upside -62%
Expected +16% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on HAE : 60% (10 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+17.0%
stock +17% · XLV +5%
matured Aug 2, 17
▲ Buy · 🎯$40
Price at call : $33.55 — upside +19%
Today : $105 — upside -62%
Expected +19% · Actual +21% · Reason (≥ +15%) : ✓ Yes
🎯 on HAE : 60% (10 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+21.5%
stock +21% · XLV +8%
matured Feb 1, 17
▲ Buy · 🎯$47
Price at call : $39.25 — upside +20%
Today : $105 — upside -55%
Expected +20% · Actual -24% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 60% (10 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
-24.0%
stock -24% · XLV -2%
matured Jul 27, 16
▲ Buy · 🎯$48
Price at call : $41.64 — upside +15%
Today : $105 — upside -54%
Expected +15% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 60% (10 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
-20.1%
stock -20% · XLV -3%
matured Apr 27, 16
▲ Buy · 🎯$45
Price at call : $37.16 — upside +21%
Today : $105 — upside -57%
Expected +21% · Actual -15% · Reason (≥ +15%) : ✗ No
🎯 on HAE : 60% (10 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
-15.3%
stock -15% · XLV +4%
matured Jan 5, 16
▲ Buy · 🎯$38
Price at call : $34.68 — upside +10%
Today : $105 — upside -64%
Expected +10% · Actual +19% · Reason (≥ +15%) : ✓ Yes
🎯 on HAE : 60% (10 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+19.4%
stock +19% · XLV +27%
matured May 22, 15
▲ Buy · 🎯$36
Price at call : $30.36 — upside +19%
Today : $105 — upside -66%
Expected +19% · Actual +34% · Reason (≥ +15%) : ✓ Yes
🎯 on HAE : 60% (10 calls matureds) · 📊 on Health : 49.1% · +10.3% (112 calls)
+33.5%
stock +34% · XLV +23%
matured Apr 30, 15
Frequently asked questions
Should I buy Haemonetics stock?
This isn't buy advice. For Haemonetics, the analyst consensus is "Buy", with an average price target of $92.00 (-12% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 60% of the time (5 calls tracked on Haemonetics). We show the numbers — you decide.
Is it too late to buy Haemonetics? How high can it go?
The most bullish analyst target on Haemonetics is $119 (+13% above today's price); the average is $92.00. That's the upside they see. Check how reliable those analysts have actually been on Haemonetics on our site before trusting it.
Is Haemonetics still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 8 analysts have a real record on Haemonetics, the best hitting 60% over 5 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Haemonetics? The case for and against
The arguments for and against, one by one, from the numbers: why invest in HAE (and why hesitate).
What has Haemonetics's past performance been?
Historical returns and a "how much if I had invested" calculator: HAE performance & returns.
What is the best month to buy HAE?
The 12 months ranked by the stock's past returns: best & worst month to buy HAE.
BIIB 
VRTX 
UNH 
REGN 
EW 
SRPT 
VEEV 
BSX